Severe delayed adverse reactions to non-steroidal anti-inflammatory drugs (NSAIDs)

Clinical and Experimental Allergy, Supplement

Volumn 28, Issue 4, 1998, Pages 47-51

  Hernandez Fernandez De Rojas, D ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; DICLOFENAC; DIFLUNISAL; EOSINOPHIL CATIONIC PROTEIN; INDOMETACIN; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; OXICAM DERIVATIVE; PARACETAMOL; PHENYLBUTAZONE; PROPIONIC ACID DERIVATIVE; PYRAZOLONE DERIVATIVE; SULINDAC;

ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT BLOOD LEVEL; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EXFOLIATIVE DERMATITIS; HUMAN; INCIDENCE; INFLAMMATION; INTRACUTANEOUS TEST; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SKIN TEST; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; TOXIC EPIDERMAL NECROLYSIS; VASCULITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED;

EID: 0031679993     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Boletin de Faramacovigilancia de la Comunidad Valenciana. 1996; 37: 541-9.
2. Alergia a medicamentos. In: Sociedad Española de Alergologia e Inmunología Clínica, ALK-Abello, eds Alergologica. Madrid. 1995, 187-213.
3. Boletin de Farmacovigilancia de la Comunidad Valenciana. 1995; 33: 480-7.
4. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85.
5. Hoigné R, Jaeger M, D'A, Wymann R et al. Time pattern of allergic reactions to drugs. In: Weber E, Lawson DH, Hoigné R, eds Risk Factors for Adverse Drug Reactions. Basel, Birkhäuser, 1990.
6. Roujeau J-C, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med, 1995; 333: 1600-7.
7. Schöpf E, Stühmer A, Rzany B et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome: an epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-42.
8. Roujeau J-C, Guillaume J-C, Fabré J-P et al. Toxic epidermal necrolysis (Lyell's syndrome). Incidence and drug etiology in France, 1981-85. Arch Dermatol 1990; 126: 37-42.
9. Guillaume J-C, Roujeau J-C, Revuz J et al. The culprit drug in 87 cases of toxic epidermal necrolysis (Lyell's syndrome). Arch Dermatol 1987; 123: 1166-70.
10. Kuokkanen K. Drug eruptions: A series of 464 cases in the Departement of Dermatology University of Turku, Finland, during 1966-70. Acta Allergologica 1972; 27: 407-438.
11. Chan LK, Winearls CG, Oliver DO et al. Acute interstitial nephritis and erythroderma associated with diflunisal. Br Med J 1980; 280: 84.
12. Levitt L, Pearson RW. Sulindac-induced Stevens-Johnson toxic epidermal necrolysis syndrome. JAMA 1980; 243: 1262-3.
13. Martin T, Pasquali JL, Welsch M et al. Intolérance au fenbufèneune observation de toxidermie sévère. Press Med 1984; 13: 43-4.
14. Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis. Arch Dermatol 1984; 120: 484-9.
15. Millard LGA. Haemorragic bullous eruption of the hands caused by phenylbutazone: A report of 3 cases. Acta Dermatovener (Stockholm) 1977; 57: 83-6.
16. Marsh FP, Almeyda JR, Levy IS. Non-thrombocytopenic purpura and acute glomerulonephritis after indomethacin therapy. Ann Rheum Dis 1971; 30: 501-5.
17. Stern RS, Bigby M. An expanded profile of cutaneous reactions to nonsteroidal antiinflammatory drugs: Report of a specialty based for spontaneous reporting of adverse reactions to drugs. JAMA 1984; 252: 1433-7.
18. Goebel KM, Mueller-Brodman W. Reversible overt nephropathy with Henoch-Schönlein purpura due to piroxicam. Br Med J 1982; 284: 311-2.
19. Malik S, Athurton I, Griffith ID. Mefenamic acid nephropathy (letter). Lancet 1980; ii: 7746.
20. Margolis RJ et al. Lymphocyte subsets and Langerhans cells/indeterminate cells in eryhtema multiforme. J Invest Dermatol 1983; 81: 403.
21. Pichler WJ, Zanni M, Schynder B et al. Characterization of Drug-Specific T Cells. En: Progress in Allergy and Clinical Immunology. Oehling AK, Huerta López JG, eds Hogrefe & Huber Publishers. Göttingen, Germany. 1997: 368-371.
22. Gonzalez FJ, Carvajal MJ, Leiva L et al. Expression of the cutaneous lymphocyte-associated antigen in circulating T cells in drug-allergic reactions. Int Arch Allergy Immunol 1997; 113: 345-7.
23. Fernández J, Blanca M, Moreno F et al. Role of tryptase, eosinophil cationic protein and histamine in immediate allergic reactions to drugs. Int Arch Allergy Immunol 1995; 107: 160-2.
24. Genovese A, Stellato C, Marsella CV, Adt M, Marone G. Role of mast-cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int Arch Allergy Immunol 1996; 110: 13-22.
25. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity. J Clin Invest 1988; 82: 1826.
26. Rieder MJ, Shear NH, Kanee A et al. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmr 1991; 49: 13-7.
27. Spielberg SP et al. Predisposition to phenitoyn hepatotoxicity assessed in vitro. N Engl J Med 1981; 307: 122.